Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis

Area of Science:

• Nephrology
• Pharmacology
• Hepatology

Background:

• The Cockcroft-Gault (CG) equation is widely used by healthcare professionals to estimate renal function.
• Clinicians may overlook the limitations of the original serum creatinine (SCr)-based equation and its variations.
• Cirrhosis causes falsely low SCr, leading to overestimated renal function when using the CG equation.

Purpose of the Study:

• To review the original CG trial and subsequent alterations to the equation.
• To describe the pathophysiology of cirrhosis and its impact on renal function estimation.
• To evaluate the accuracy of different CG equation manipulations for estimating creatinine clearance (CrCl) in various populations, particularly cirrhotic patients.

Main Methods:

• Review of the original 1976 Cockcroft-Gault trial data.
• Analysis of clinician-specific alterations to the CG equation over time.
• Examination of studies estimating renal function in cirrhotic patients, considering hemodynamic changes and pathophysiology.

Main Results:

• Evidence for the most accurate CG equation manipulation in cirrhotic patients was inconclusive.
• Eliminating body weight from the CG equation yielded estimates closest to measured CrCl.
• "Rounding up" SCr values often underestimated CrCl, potentially leading to suboptimal drug dosing.
• SCr-based methods, including the CG equation, overestimated true renal function by approximately 50% in cirrhotic patients.

Conclusions:

• The homogeneity of the original CG trial population limits its external validity.
• Modifications to the CG equation are necessary to improve accuracy, especially in specific patient groups like those with cirrhosis.
• Overestimation of renal function in cirrhotic patients using SCr-based methods necessitates further research for precise CrCl estimation and appropriate drug management.